Dr. Reddy's Laboratories Ltd. closed 6.97% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

falling 0.54% to 83,606.46. Dr. Reddy's Laboratories Ltd. closed 9.61% short of its 52-week high of 1,420.20 rupees, which the company reached on August 21st.

Dr Reddys Laboratories stock flat in today's session amid high volume trading The latest price stands at Rs 1282.90, reflecting the market's response to these factors.

Mumbai, July 2 -- Dr Reddys Laboratories Ltd is down for a fifth straight session today. The stock is quoting at Rs 1267.7, down 0.71% on the day as on 13:19 IST on the NSE.

Sean ‘Diddy’ Combs was acquitted of racketeering and sex trafficking but convicted of transporting individuals for prostitution. Explore the legal breakdown and trial implications.

Republican Brandon Gill faced backlash for a racist remark after posting a video of Indian-origin mayoral candidate Zohran Mamdani eating rice with his hands. Social media users criticised Gill ...

Study assessed the efficacy and safety of rosuvastatin monotherapy, extended-release (ER) niacin monotherapy, or rosuvastatin and ER niacin combined therapy in patients with atherogenic dyslipidemia.

Find information on doxycycline's cost, how generic and brand-name prices compare, what financial assistance is available, and more.

The potential benefits of antidepressants outweigh the risks for adolescents, but family and psychological interventions are most effective for younger children.